The final versions of the updated Guidelines for Patent Examination and the Implementing Rules for the Patent Law were released by the China National Intellectual
Secukinumab, an IL-17A antagonist, is marketed by Novartis under the brand name Cosentyx®. In 2023, Cosentyx® observed the sales of 5 billion dollars, inclusive of
The Pharmaceutical Industry of India plays a very important role around the globe. It is one of the largest generic medicine providers in the world.
Regeneron and Bayer’s blockbuster drug, Aflibercept (Eylea®) gained its first approval in the US and the EU for Neovascular (Wet) Age-Related Macular Degeneration (AMD) in
Patent is a type of intellectual property right that provides protection over novel inventions and, gives the innovator an exclusive right to sell, use, create
Eliquis to face generic competition in late 2026? Bristol Myers Squibb (BMS) and Pfizer’s oral blood thinner – Eliquis® (Apixaban) was approved in the United
